AtheroPharma Inc.
Overview
AtheroPharma Inc. is a biotechnology company focused on developing innovative therapies for cardiovascular diseases. Its research is centered around targeting atherosclerosis, with an aim to improve patients' quality of life through breakthrough treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to AtheroPharma Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this AtheroPharma Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.